Researchers Develop New Procedure to Screen All 46 Human Chromosomes to Identify Abnormalities ... ( New technology developed by researche...)

Researchers Develop New Procedure to Screen All 46 Human Chromosomes to Identify Abnormalities in Embryos

Date:10/18/2007

New technology developed by researchers at Reproductive Medicine Associates of New Jersey awarded General Program Prize Paper at American Society for

Reproductive Medicine Annual Meeting

WASHINGTON and MORRISTOWN, N.J., Oct. 18 /PRNewswire/ -- Researchers at Reproductive Medicine Associates of New Jersey (RMA) received the highest award for research at the American Society for Reproductive Medicine (ASRM) for developing a novel technology making it possible to provide accurate, rapid analysis of all 46 human chromosomes from a single cell taken from a human embryo. The ASRM Prize Paper Award is awarded to the most significant research in the field of human reproduction each year. This new technology makes it possible for the first time to fully evaluate the genetic make up of human embryos in a time frame which allows clinicians and scientists to use that information to help improve pregnancy rates, reduce miscarriage risk, and decrease the risk of some major congenital anomalies such as Down syndrome.

This procedure, known as "Accurate 23 chromosome aneuploidy screening in human blastomeres using single nucleotide polymorphisms (SNP)," provides fertility specialists for the first time with a rapid and accurate technique to assess the genetic normality of human embryos created through in vitro fertilization (IVF).

The results of this research effort were presented this week at the American Society for Reproductive Medicine (ASRM) meeting and were awarded the General Program Prize Paper Award, the highest award provided by this international professional society. Nathan Treff, Ph.D., lead author on the study and a researcher in molecular genetics at RMA, delivered the results in an oral presentation. "Accurate and rapid identification of chromosomally- abnormal (aneuploid) embryos within hours after embryo biopsy will provide physicians with the ability to select embryos for transfer to the uterus based on a far more compl
'/>"/>

SOURCE Reproductive Medicine Associates of New Jersey
Copyright©2007 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3
Related medicine technology :

1. NIEHS Researchers Identify Enzyme Critical in DNA Replication
2. Stanford Researchers Find Brain Pathway of Depression in Rats
3. Researchers Discover Method for Identifying How Cancer Evades the Immune System
4. Researchers Discover Gene For Rare Skin Disorder
5. Prolexys Pharmaceuticals and Columbia University Researchers Publish Study on Anti-Tumor Properties of a Selective Small Molecule Anti-Tumor Agent With Novel Mechanism of Action
6. NCI Researchers Discover Genes That Are Turned on at High Levels in Tumor-associated Blood Vessels of Mice and Humans
7. Stanford Researchers Track Human Stem Cells Transplanted Into Rat Brain
8. Dasatinib Shows High Early Response Rate as First Treatment for Chronic Myelogenous Leukemia, M. D. Anderson Researchers Report
9. World First Medical Treatment Announced by Researchers at Queen Mary University London and University of Leicester
10. Researchers Urge Caution in Using ESAs for Cancer-Related Anemia
11. Researchers Identify New Genetic Risk Factors for Type 2 Diabetes

Post Your Comments:

(Date:5/20/2013)... BETHESDA, Md. , May 20, 2013 TNI ... diseases through the activation and mobilization of the body,s ... trading on the OTC Markets, OTCQB marketplace under the ... able to view the real-time Level II stock quotes ... Noreen Griffin , CEO of TNI BioTech, ...

(Date:5/20/2013)... Ill. , May 20, 2013 AbbVie ... initiation of a Phase 3 clinical study called ... assess the effects of the investigational compound atrasentan - ... of kidney disease in patients with stage 2 ... 2 diabetes. SONAR is a large, multinational, double-blind, ...

(Date:5/19/2013)... , May 20, 2013 Whole-cell pertussis vaccines were ... vaccines during a large recent outbreak, according to a ... Whole-cell pertussis vaccines, also called DTwP, were available from ... concerns that ultimately led to the development of acellular ... late 1990s, the United States ...

Breaking Medicine Technology:TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 2 TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace 3 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 2 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 3 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 4 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 5 AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy 6 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 2 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 3 Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak 4

[0] TNI BioTech, Inc. Stock to Begin Trading on the OTCQB Marketplace [0] AbbVie Initiates Phase 3 Study of Its Investigational Compound Atrasentan on Renal Outcomes in Patients with Diabetic Nephropathy [0] Study Shows Whole-Cell Vaccine was More Effective than Acellular Vaccine During California Pertussis Outbreak

... 2012 Covance Inc. (NYSE: CVD ) said ... repurchase of up to $300 million of its outstanding ... approximately 800,000 shares remaining under a previously-announced repurchase authorization ... common stock. Any purchases under this buyback would be ...

... leading medical practice providing specialized infertility treatment since 1986, ... test that will replace daily blood tests needed to ... Boston IVF has proven that the hormone estradiol, traditionally ... in saliva, virtually eliminating the need for daily blood ...

Cached Medicine Technology:Covance Board Authorizes $300 Million Stock Buyback 2 Boston IVF Pioneers World's First Needle-Free Saliva Test Used in Infertility Treatment; Patient Friendly Monitoring Replaces Daily Blood Tests 2 Boston IVF Pioneers World's First Needle-Free Saliva Test Used in Infertility Treatment; Patient Friendly Monitoring Replaces Daily Blood Tests 3

Covance Board Authorizes $300 Million Stock Buyback Boston IVF Pioneers World's First Needle-Free Saliva Test Used in Infertility Treatment; Patient Friendly Monitoring Replaces Daily Blood Tests

(Date:5/20/2013)... from Comfort & Harmony was featured at ... Association (USLCA) May 2nd – 5th. The conference hosted ... , The USLCA annual conference is a trade ... about the latest trends in lactation. , Mombo ... new mothers use to help support infants while breastfeeding. ...

(Date:5/20/2013)... 2013 Mirena IUD lawsuit ... litigation recently established in U.S. District Court, Southern District ... to court records, the litigation’s first Status Conference was ... Plaintiff’s leadership positions were discussed. So far, at ... District of New York, all of which allege that ...

(Date:5/20/2013)... 2013 Co-founder of Atlanta SEO ... keynote speaker at the 5th International INVEST Domaining & ... brings together company representatives and independent individuals from around ... marketing and investments. , The 2013 conference will take ... México from May 20 to 21. A networking city ...

(Date:5/20/2013)... Nearly 20 percent of kidneys that are recovered ... transplant due to factors ranging from scarring in small ... organ going too long without blood or oxygen. But, ... be "recycled" to help solve the critical shortage of ... Center and colleagues, reporting in the journal Biomaterials ...

(Date:5/20/2013)... 2013 Horizon NJ Health, New Jersey’s ... that it has earned a Commendable Accreditation status ... NJ Health is a wholly owned subsidiary of Horizon ... NCQA Health Plan Accreditation is a nationally recognized program ... health plans provide to their members. Health Plan Accreditation ...

Breaking Medicine News(10 mins):Health News:Comfort & Harmony™ Exhibited mombo™ Nursing Pillow at USLCA’s First Inaugural Conference 2 Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 2 Health News:Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation 3 Health News:EverSpark CEO to be Keynote Speaker at 5th International INVEST Domaining & Internet Marketing Conference in Mexico City 2 Health News:Study suggests new source of kidneys for transplant 2 Health News:Horizon NJ Health Awarded Commendable Accreditation by NCQA 2 Health News:Horizon NJ Health Awarded Commendable Accreditation by NCQA 3

[0] Comfort & Harmony™ Exhibited mombo™ Nursing Pillow at USLCA’s First Inaugural Conference [0] Mirena IUD Lawsuit News: Bernstein Liebhard LLP Reports on First Status Conference in Federal Mirena Litigation [0] EverSpark CEO to be Keynote Speaker at 5th International INVEST Domaining & Internet Marketing Conference in Mexico City [0] Study suggests new source of kidneys for transplant [0] Horizon NJ Health Awarded Commendable Accreditation by NCQA

... ST. LOUIS, Nov. 10 KV Pharmaceutical Company,(NYSE: KVa/KVb) ... previously announced, the Company will be delayed in the ... fiscal 2009. The Company expects to,file a Form 12b-25 ... on Wednesday, November 12, 2008., About KV Pharmaceutical ...

... Left-handed pitcher Jon Lester, who,came back from an off-season ... Boston Red Sox in the 2007 World Series, will ... to a Major League Baseball player,who best exemplifies the ... on and off the field., The 24-year-old Tacoma, ...

... analysis of 33 research projects , , MONDAY, Nov. 10 (HealthDay ... as beta blockers has concluded that they are not useful ... using beta blockers for non-coronary surgery may actually increase the ... conducted the study -- known as a meta-analysis -- recommend ...

... cardiopulmonary bypass does not cause short-term neurological problems ... complex heart defects, according to pediatric researchers. The ... showed adverse neurological effects after newborn surgery for ... news for school-aged children who receive surgery for ...

... 10 A Guide to Implementing,GASB 45, a new issue ... how North Carolina local governments are meeting their,obligations to report ... which is based on a survey of the 30 local ... reports that:, -- 88 percent of the ...

... Net Revenue Increased 93.6% to US$146.5 million; Non-GAAP Gross Margins ... ... 10 /Xinhua-PRNewswire-FirstCall/ -- Mindray,Medical International Limited (NYSE: MR ), a ... selected,unaudited financial results for the third quarter and nine months ended,September ...

KV Pharmaceutical to File Form 12b-25 on November 12, 2008 Red Sox Pitcher Jon Lester Wins 2008 Hutch Award(R)Beta Blocker Use Questioned in Non-Heart Surgery No drop in IQ seen after bypass for child heart surgery A Guide to Implementing GASB 45 Mindray Announces 2008 Third Quarter and Nine Months Results

... Keeler Galilean loupes are ideal ... when increased magnification and a large ... loupes are laser aligned, lightweight and ... ,Fixed working distance and superior depth ...

U tip irrigation-aspiration cannual designed for manual removal of 12 oclock cortex. 23 gauge thin wall irrigation and aspiration lines for maximum aspiration capabilities. Polished finish. Overall l...

... pneumatic stools come with five legs ... of 18" to 25" (total vertical ... hard rubber castors. Comfortable, durable and ... vinyl as standard, other colors available ...

Anterior Stromal Puncture Cannula, 25 g. For treatment of recurrent corneal erosion. Overall length 24 mm. 5/box....

Medicine Products:

SuperVu Galilean System Vukich Irrigating-Aspirating Cannula Reliance Stools, Model 5340 Anterior Stromal Puncture Cannula, 25 g